What Researchers Did
Researchers examined the outcomes of 7 patients who received hyperbaric oxygen therapy (HBOT) as an additional treatment after undergoing surgery to repair bladder fistulas.
What They Found
All 7 patients, including 6 with vesicovaginal fistula and 1 with colovesical fistula, received HBOT once daily for 10 consecutive days starting on the first postoperative day. No patients experienced any adverse reactions during the HBOT course, and all achieved an uneventful recovery with no recurrence of symptoms observed during 3-12 months of follow-up.
What This Means for Canadian Patients
This study suggests that HBOT could be a safe and effective adjunctive therapy for Canadian patients recovering from bladder fistula repair surgery. Although bladder fistulas are less common in Canada, they can arise as complications from gynecological surgeries, and HBOT may help promote healing and prevent recurrence.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a small case report involving only 7 patients, which limits the generalizability of its findings.